R
Ramachandran Murugesan
Researcher at Chettinad University
Publications - 24
Citations - 598
Ramachandran Murugesan is an academic researcher from Chettinad University. The author has contributed to research in topics: Mesenchymal stem cell & Stem cell. The author has an hindex of 9, co-authored 24 publications receiving 354 citations.
Papers
More filters
Journal ArticleDOI
Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives
Antara Banerjee,Surajit Pathak,Vimala Devi Subramanium,G Dharanivasan,Ramachandran Murugesan,Rama Shanker Verma +5 more
TL;DR: The present review focuses on recent approaches for colon-specific drug delivery (CDDS) and aims to unveil the emerging possibilities and advances in the treatment of CC with CDDS.
Journal ArticleDOI
Health hazards of nanoparticles: understanding the toxicity mechanism of nanosized ZnO in cosmetic products
Vimala Devi Subramaniam,Suhanya Veronica Prasad,Antara Banerjee,Madhumala Gopinath,Ramachandran Murugesan,Francesco Marotta,Xiao-Feng Sun,Surajit Pathak +7 more
TL;DR: In this review article, the characteristics of metal oxide nanoparticles and its applications in the cosmetic industry are discussed and their toxicity effects and their impact on human health are highlighted.
Journal ArticleDOI
Studies on polymer-coated zinc oxide nanoparticles: UV-blocking efficacy and in vivo toxicity.
TL;DR: One of the reasons for better survival of zebrafish embryos could be attributed to lower aggregation of ZnO-CTS nanoparticles atop eggs thereby facilitating the breathing of embryos.
Journal ArticleDOI
Antibacterial activity of agricultural waste derived wollastonite doped with copper for bone tissue engineering.
Azeena S,Namasivayam Subhapradha,Nagarajan Selvamurugan,Shoba Narayan,N. Srinivasan,Ramachandran Murugesan,Chung Tw,A. Moorthi +7 more
TL;DR: The biocompatibility in mouse Mesenchymal Stem cells showed the non-toxic effect up to 0.05mg/ml concentration while the increase in concentration was found to be toxic to the cells, suggesting that the particles may have better potential application with the challenging prevention of post implantation infection in the field of bone tissue engineering (BTE).
Journal Article
Concise Review on Clinical Applications of Conditioned Medium Derived from Human Umbilical Cord-Mesenchymal Stem Cells (UC-MSCs).
Sushmitha Sriramulu,Antara Banerjee,Rosa Di Liddo,Ganesan Jothimani,Madhumala Gopinath,Ramachandran Murugesan,Francesco Marotta,Surajit Pathak +7 more
TL;DR: The isolated umbilical cord-derived mesenchymal stem cells are cultured in the Dulbecco’s Modified Eagle's Medium, and thereby it begins to release soluble factors into the medium during the period of culture which is termed as conditioned medium, which has both differentiation capacity and therapeutic functions.